Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - dobutamine hydrochloride, quantity: 14 mg/ml (equivalent: dobutamine, qty 12.5 mg/ml) - injection, concentrated - excipient ingredients: sodium hydroxide; hydrochloric acid; water for injections; sodium metabisulfite - adults who require short-term treatment of cardiac failure secondary to acute myocardial infarction, or cardiac surgery.

Kanada - angleščina - Health Canada

pharmaceutical partners of canada inc - dobutamine (dobutamine hydrochloride) - solution - 12.5mg - dobutamine (dobutamine hydrochloride) 12.5mg - selective beta 1-adrenergic agonists

Združene države Amerike - angleščina - NLM (National Library of Medicine)

a-s medication solutions - dobutamine hydrochloride (unii: 0wr771djxv) (dobutamine - unii:3s12j47372) - dobutamine hydrochloride in 5% dextrose injection is indicated when parenteral therapy is necessary for inotropic support in the short-term treatment of patients with cardiac decompensation due to depressed contractility resulting either from organic heart disease or from cardiac surgical procedures. experience with intravenous dobutamine in controlled trials does not extend beyond 48 hours of repeated boluses and/or continuous infusions. whether given orally, continuously intravenously, or intermittently intravenously, neither dobutamine nor any other cyclic-amp-dependent inotrope has been shown in controlled trials to be safe or effective in the long-term treatment of congestive heart failure. in controlled trials of chronic oral therapy with various such agents, symptoms were not consistently alleviated, and the cyclic-amp-dependent inotropes were consistently associated with increased risks of hospitalization and death. patients with nyha class iv symptoms appeared to be at particular risk. dobutamine hy

Singapur - angleščina - HSA (Health Sciences Authority)

pfizer private limited - dobutamine hcl eqv dobutamine - injection - 12.5 mg/ml - dobutamine hcl eqv dobutamine 12.5 mg/ml

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - dobutamine hydrochloride, quantity: 14.01 mg/ml (equivalent: dobutamine, qty 12.5 mg/ml) - injection, solution - excipient ingredients: sodium metabisulfite; water for injections - dobutamine hydrochloride injection is indicated in adults who require short-term treatment of cardiac failure secondary to acute myocardial infarction, or cardiac surgery.

Malta - angleščina - Medicines Authority

wockhardt uk limited ash road north, wrexham, ll13 9uf, united kingdom - dobutamine - concentrate for solution for infusion - dobutamine 12.5 mg/ml - cardiac therapy

Malta - angleščina - Medicines Authority

cherubino limited delf building, sliema road, gzira, gzr 1637, malta - dobutamine - concentrate for solution for infusion - dobutamine 12.5 mg/ml - cardiac therapy

Malta - angleščina - Medicines Authority

claris lifesciences uk limited - dobutamine - concentrate for solution for infusion - dobutamine 12.5 milligram(s)/millilitre - cardiac therapy

Malta - angleščina - Medicines Authority

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - dobutamine - concentrate for solution for infusion - dobutamine 12.5 mg/ml - cardiac therapy

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - dobutamine hydrochloride, quantity: 14.01 mg/ml (equivalent: dobutamine, qty 12.5 mg/ml) - injection, concentrated - excipient ingredients: sodium metabisulfite; hydrochloric acid; sodium hydroxide; water for injections - adults who require short-term treatment of cardiac failure secondary to acute myocardial infarction, or cardiac surgery.???